Aptahem Information

View Top Employees from Aptahem

Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation are involved. The company’s primary pharmaceutical candidate, Apta-1, is being developed with the aim of preventing the high mortality rate caused by organ and tissue damage in patients diagnosed with a septic condition, among others. The company holds patent protection in strategic target markets and actively seeks business development opportunities with potential collaborators.

Website	https://aptahem.com/
Revenue	$9 million
Employees	5 (2 on RocketReach)
Founded	2014
Address	58 Norra Vallgatan, Malmoe, Skane 211 22, SE
Phone	+46 76 633 36 99
Industry	Biotechnology Research, Business Services General, Business Services
Keywords	Aptamer Therapeutics, Coagulation Disorders, Inflammation Treatment, Anti Inflammatory Drugs, Life Threatening Diseases, Thrombosis Treatment, Blood Clotting Disorders, Pharmaceutical Development, Biotechnology, Therapeutic Antibodies, Drug Development, Hemostasis, Innovative Medicines, Pharmaceutical Research, Clinical Trials, New Drug Discovery, Rare Diseases
Competitors	Amgen, BioMarin Pharmaceutical Inc., Zymeworks Inc., REGENXBIO Inc., Cellectis, Sorrento Therapeutics, Inc., Athenex, Aptevo Therapeutics Inc, Galmed Pharmaceuticals Ltd., Accelera Corporation +37 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies